journal article·2022-09-27

In Situ Upregulating Heat Shock Protein 70 via Gastric Nano-Heaters for the Interference of Helicobacter pylori Infection

Xin Xia, Zhiwei Yin, Yanxia Yang, Shengkai Li, Linlin Wang, Xinqi Cai, Yiting Xu, Chao Ma, Ye Qiu, Zhuo Chen, Weihong Tan

ACS Nano· Volume 16· Issue 9
Publisher page

Abstract

Taking inspiration from the mechanism of Helicobacter pylori infection can lead to innovative antibacterial ways to fight antibiotics resistance. Herein, a gastric nano-heater iron–cobalt alloy shielded with graphitic shells (FeCo@G) is developed to interfere with H. pylori infection under an alternating magnetic field. FeCo@G shows a high and stable specific loss power (SLP = 534.1 W g-1) in the acidic environment and provides efficient magnetothermal stimulation in the stomach. Such stimulation upregulates the cytoprotective heat shock protein 70 (HSP70) in gastric epithelial cells, which antagonizes the infection of H. pylori. This finding is further supported by the transcriptomic analysis verifying the upregulation of HSP70 in the stomach. Moreover, the nano-heater shows a high inhibition rate of H. pylori in vivo with good biocompatibility; 95% of FeCo@G is excreted from the mouse’s gastrointestinal tract within 12 h. In summary, FeCo@G allows magnetothermal therapy to be used in harsh gastric environments, providing an approach for the therapy against H. pylori.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Magnetic and Electromagnetic Effects · Calcium Carbonate Crystallization and Inhibition · Hydrogen Storage and Materials

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Molecular Science and Biomedicine Laboratory (MBL), State Key Laboratory of Chemo/Biosensing and Chemometrics, College of Chemistry and Chemical Engineering, College of Biology, Aptamer Engineering Center of Hunan Province, Hunan University, Changsha, Hunan 410082, People’s Republic of China

Key Laboratory of Theoretical Organic Chemistry and Function Molecule, Ministry of Education, School of Chemistry and Chemical Engineering, Hunan University of Science and Technology, Xiangtan, Hunan 411201, People’s Republic of China

College of Materials Science and Engineering, Hunan University, Changsha, Hunan 410082, People’s Republic of China

The Cancer Hospital of the University of Chinese Academy of Sciences (Zhejiang Cancer Hospital), Institute of Basic Medicine and Cancer (IBMC), Chinese Academy of Sciences, Hangzhou, Zhejiang 310022, People’s Republic of China

Institute of Molecular Medicine (IMM), Renji Hospital, School of Medicine and College of Chemistry and Chemical Engineering, Shanghai Jiao Tong University, Shanghai 200240, People’s Republic of China

Funding

Ministry of Science and Technology of the People's Republic of China · Science and Technology Program of Hunan Province · National Natural Science Foundation of China

References (43)

Show source-provided references
1. IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. Schistosomes, liver flukes and Helicobacter pylori. 1; IARC: Lyon, 1994; p 61.
2. 10.1111/apt.1456110.1111/apt.14561 ↗
3. 10.1038/s41575-021-00449-x10.1038/s41575-021-00449-x ↗
4. 10.1007/s00253-020-10945-w10.1007/s00253-020-10945-w ↗
5. 10.1093/jn/137.3.812S10.1093/jn/137.3.812S ↗
6. 10.3389/fmicb.2020.0170510.3389/fmicb.2020.01705 ↗
7. 10.1002/anie.20190628010.1002/anie.201906280 ↗
8. Targosz A. · J. Physiol. Pharmacol. · 2006 · 57 · 265
9. 10.1155/2014/79434210.1155/2014/794342 ↗
10. 10.1007/s00011-012-0487-x10.1007/s00011-012-0487-x ↗
11. 10.1046/j.1440-1746.2000.02144.x10.1046/j.1440-1746.2000.02144.x ↗
12. 10.1002/pmic.20040095110.1002/pmic.200400951 ↗
13. 10.1016/S0952-7915(01)00297-710.1016/S0952-7915(01)00297-7 ↗
14. 10.1111/j.1745-7254.2007.00589.x10.1111/j.1745-7254.2007.00589.x ↗
15. 10.1016/j.intimp.2013.04.00510.1016/j.intimp.2013.04.005 ↗
16. 10.1186/1471-230X-11-14610.1186/1471-230X-11-146 ↗
17. 10.1016/j.lfs.2006.01.01310.1016/j.lfs.2006.01.013 ↗
18. 10.1007/BF0217218810.1007/BF02172188 ↗
19. 10.1126/scitranslmed.aau858110.1126/scitranslmed.aau8581 ↗
20. Teng L. S. · Hepatobiliary Pancreat. Dis. Int. · 2010 · 9 · 361
21. 10.3390/cancers1205108210.3390/cancers12051082 ↗
22. 10.1007/s00262-016-1891-910.1007/s00262-016-1891-9 ↗
23. 10.1002/ange.20170554310.1002/ange.201705543 ↗
24. 10.1126/science.126182110.1126/science.1261821 ↗
25. 10.1002/ange.20130655710.1002/ange.201306557 ↗
26. 10.1016/j.addr.2018.10.01610.1016/j.addr.2018.10.016 ↗
27. 10.1016/j.nantod.2017.02.00610.1016/j.nantod.2017.02.006 ↗
28. 10.3402/nano.v1i0.535810.3402/nano.v1i0.5358 ↗
29. 10.1021/acsnano.9b0832010.1021/acsnano.9b08320 ↗
30. 10.1038/nmat177510.1038/nmat1775 ↗
31. Testerman T. L. · 2001 · 34
32. Lee A. · Eur. J. Gastroenterol Hepatol · 1995 · 7 · 461
33. 10.1136/gut.23.6.51310.1136/gut.23.6.513 ↗
34. 10.4315/0362-028X-61.8.92910.4315/0362-028X-61.8.929 ↗
35. 10.1016/j.jmmm.2019.04.07610.1016/j.jmmm.2019.04.076 ↗
36. 10.1002/eji.20042560310.1002/eji.200425603 ↗
37. 10.1016/j.cell.2022.02.00410.1016/j.cell.2022.02.004 ↗
38. 10.1126/sciadv.aaz373410.1126/sciadv.aaz3734 ↗
39. 10.1038/s41565-019-0521-z10.1038/s41565-019-0521-z ↗
40. 10.1021/acsnano.0c0725810.1021/acsnano.0c07258 ↗
41. 10.1111/j.1523-5378.2011.00926.x10.1111/j.1523-5378.2011.00926.x ↗
42. 10.1111/hel.1254410.1111/hel.12544 ↗
43. 10.1111/hel.1279610.1111/hel.12796 ↗